ロード中...
Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting
PURPOSE: Imatinib inhibits platelet-derived growth factor receptor (PDGFR), and evidence shows that PDGFR participates in the development and progression of cervical cancer. Although imatinib has exhibited preclinical activity against cervical cancer, only minimal clinical therapeutic efficacy was o...
保存先:
主要な著者: | , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Dove Medical Press
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019625/ https://ncbi.nlm.nih.gov/pubmed/24855354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S60178 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|